Las Vegas, NV -- (SBWIRE) -- 01/14/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: AllianceBernstein Income Fund Inc.(NYSE:ACG), Navios Maritime Holdings Inc.(NYSE:NM), Synta Pharmaceuticals Corp.(NASDAQ:SNTA), The Jones Group Inc.(NYSE:JNY)
AllianceBernstein Income Fund Inc.(NYSE:ACG) was a volume gainer of 2.51 million shares and the average volume of the stock remained 1.23 million shares. The stock opened the session at $7.48 and finished at the end of the day at $7.48 and the stock escalated 0.27%.The market capitalization of the stock remained 1.83 billion. AllianceBernstein Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund is designed to provide current income consistent with the preservation of capital. The Fund normally invests at least 80% of its net assets in income-producing securities.
For How Long ACG will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Navios Maritime Holdings Inc.(NYSE:NM) exchanged 2.50 million shares and the average volume remained 1.19 million shares. The stock closed the session at $8.88 with the drop of -1.44%. Navios Maritime Holdings Inc. (Navios Holdings) is a global, vertically integrated seaborne shipping and logistics company which operates numerous businesses focused on the transport and transshipment of drybulk commodities including iron ore, coal and grain.
Why Should Investors Buy NM After the Recent Fall? Just Go Here and Find Out
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) decreased -4.19% and its closing price was $6.18. The volume of the stock was 2.44 million shares and the average volume remained 1.81 million shares. The market capitalization of the stock remained 526.55 million. The beta of the stock remained 3.10. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases.
Will SNTA Get Buyers Even After The Recent Rally? Find Out Here
The Jones Group Inc.(NYSE:JNY) exchanged 2.39 million shares in the previous trading session, and its average trading remained 3.32 million shares. JNY dropped -0.13% and it closed the trading at $14.83. The market capitalization of the stock remained 1.18 billion. The Jones Group Inc. (Jones) is a global designer, marketer and wholesaler of over 35 brands with products in apparel, footwear, jeanswear, jewelry and handbags. The Company operates in six segments: domestic wholesale sportswear, domestic wholesale jeanswear, domestic wholesale footwear and accessories, domestic retail, international wholesale and international retail.
Has JNY Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)